Goutham Narla active positions
| Companies | Position | Start | End |
|---|---|---|---|
Rappta Therapeutics Oy
 Rappta Therapeutics Oy BiotechnologyHealth Technology Rappta Therapeutics Oy operates as a biopharmaceutical company. It develops anti-cancer drugs activating protein phosphatase 2A. The company was founded by Goutham Narla and Mikko Lauri Sampsa Mannerkoski on March 20, 2019 and is headquartered in Helsinki, Finland. | Founder | 20/03/2019 | - |
| Chief Tech/Sci/R&D Officer | 20/03/2019 | - | |
| Director/Board Member | 20/03/2019 | - |
Career history of Goutham Narla
Former positions of Goutham Narla
| Companies | Position | Start | End |
|---|---|---|---|
Dual Therapeutics LLC
 Dual Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Dual Therapeutics LLC develops novel therapeutics for prostate cancer, lung cancer, and acute lymphoblastic leukemia. The company was founded in 2013 and is headquartered in Cleveland, OH. | Founder | - | - |
Statistics
International
| Finland | 2 |
| United States | 2 |
Operational
| Founder | 2 |
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Health Technology | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Rappta Therapeutics Oy
Rappta Therapeutics Oy BiotechnologyHealth Technology Rappta Therapeutics Oy operates as a biopharmaceutical company. It develops anti-cancer drugs activating protein phosphatase 2A. The company was founded by Goutham Narla and Mikko Lauri Sampsa Mannerkoski on March 20, 2019 and is headquartered in Helsinki, Finland. | Health Technology |
Dual Therapeutics LLC
Dual Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Dual Therapeutics LLC develops novel therapeutics for prostate cancer, lung cancer, and acute lymphoblastic leukemia. The company was founded in 2013 and is headquartered in Cleveland, OH. | Commercial Services |
- Stock Market
- Insiders
- Goutham Narla
- Experience
